Fig. 2From: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countriesMean haemoglobin level (g/dl) in the nested cohort (n = 1002)Back to article page